Pharma/Life Sciences
Health Economics & Outcomes Research
Determining the potential value of a pharmaceutical product, diagnostic test, or medical device in a variety of candidate populations is challenging.
Clinical realism and the seamless inclusion of pricing data and adherence and compliance information makes the Archimedes Model well suited for comparative-effectiveness research and cost-effectiveness studies, as well as other health economics and outcomes research.
Disease Modeling
Understanding the nature of novel interventions in new therapeutics is an important part of a company's development strategy. Archimedes has a world-class team of scientists and physicians who will work with you to run custom simulations and build custom disease models to meet your needs.
Clinical Trial Simulations
Clinical researchers and medical affairs professionals, derive the most value from clinical trial simulations that are the hallmark of the Archimedes Model. The Model can help them determine optimal target populations or design and extend clinical trials.
The Model can run a virtual clinical trial with a million people, spanning 30 years, in three hours. This enables users to make informed decisions faster and increases the probability of success.
Portfolio Strategy
Prioritizing pipeline assets and mitigating the risk of clinical failure are business imperatives. By identifying the candidate drugs in the clinical development pipeline that offer the greatest long-term health outcomes and cost benefits, the Archimedes Model can play a significant role in an organization’s portfolio strategy.
